NCT00072332View on ClinicalTrials.gov

Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2003

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2009

Conditions
Esophageal CancerGastric CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

cisplatin

DRUG

edotecarin

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00072332 - Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter